Mar 29, 2024 | COVID-19, MedBen Analytics, Mental Health, Telehealth
It should comes as no surprise that telehealth visits saw a big upswing in early 2020, as COVID-19 began to spread. As the pandemic subsided, telehealth visits slowly dropped but still retain residual popularity. The graph below shows bimonthly telehealth utilization...
Oct 31, 2023 | COVID-19, Dental, Medical, News, Pharmacy, Premiums, Prescription, Primary Care, Specialist, Telehealth, Vision
Average annual premiums for U.S. employer-sponsored single and family health insurance coverages both rose 7% in 2023, according to a survey conducted by KFF and published in Health Affairs. While the increase is higher than in recent years, it is generally in line...
Apr 18, 2023 | Announcements, Compliance, COVID-19, News, Regulatory
You may have read that on April 10, President Biden signed House Joint Resolution 7, immediately terminating the national health emergency related to the COVID-19 pandemic under the National Emergencies Act. You also may recall that earlier this year, the Biden...
Feb 7, 2023 | Announcements, Compliance, COVID-19, Regulatory
On Monday, January 30, 2023 the Biden Administration announced that both the National Health Emergency and the HHS Public Health Emergency will end on May 11, 2023. The news came in the form of a statement of administration policy typically issued in response to...
Nov 11, 2022 | Compliance, COVID-19, Regulatory
On October 13, the Department of Health and Human Services renewed the COVID-19 public health emergency for another 90 days. This means that the Families First Coronavirus Response Act (FFCRA) requirement that health plans pay for COVID-19 testing (including antibody...
Jul 26, 2022 | Cancer, Claims, COVID-19, Heart, Mental Health, Stop-Loss
Cancer and cardiovascular conditions account for over one-third of stop-loss reimbursements, according to a recent report from stop-loss carrier Sun Life.As the chart below shows, the top three conditions represent 38% of total payments. Additionally, 70% of all...
